Advertisement
Singapore markets open in 3 hours 38 minutes
  • Straits Times Index

    3,439.88
    +24.37 (+0.71%)
     
  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     
  • Dow

    39,308.00
    -23.90 (-0.06%)
     
  • Nasdaq

    18,188.30
    +159.54 (+0.88%)
     
  • Bitcoin USD

    58,525.38
    -1,186.61 (-1.99%)
     
  • CMC Crypto 200

    1,214.06
    -47.13 (-3.74%)
     
  • FTSE 100

    8,241.26
    +70.14 (+0.86%)
     
  • Gold

    2,369.40
    0.00 (0.00%)
     
  • Crude Oil

    84.06
    +0.18 (+0.21%)
     
  • 10-Yr Bond

    4.3550
    0.0000 (0.00%)
     
  • Nikkei

    40,913.65
    +332.89 (+0.82%)
     
  • Hang Seng

    18,028.28
    +49.71 (+0.28%)
     
  • FTSE Bursa Malaysia

    1,616.75
    +1.43 (+0.09%)
     
  • Jakarta Composite Index

    7,220.89
    -7,196.75 (-49.92%)
     
  • PSE Index

    6,507.49
    +57.46 (+0.89%)
     

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2024 on Monday, July 29, 2024

MARLBOROUGH, Mass., July 02, 2024--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2024 on Monday, July 29, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.

Interested participants may listen to the call by dialing (888) 394-8218 (in the United States and Canada) or +1 (773) 305-6853 (for international callers) and referencing access code 5372869. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins.

Hologic will provide a live and webcast replay of the call on the Company’s website at www.investors.hologic.com. The call will be available there for 30 days. The webcast replay will be available approximately two hours after the call ends.

ADVERTISEMENT

About Hologic

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

SOURCE: Hologic, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240702005505/en/

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com